Encouraging announcement today from Biotron about their anti-HIV drug trials.Looks like they will be moving on to the next stage , which involves trials on humans and ,furthermore,there could be big companies wanting to link up with BIT. It has been a long wait already but I guess holding on for another year or so could eventually produce reasonable profits.There are not that many shares on issue and the stock has the backing of well-regarded scientists at the ANU. However, just wish that government sources would provide more financial support to worthwhile projects such as this so that BIT'S equity in any successful development is not watered down too much.
BIT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
